U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 187

Tests names and labsConditionsGenes, analytes, and microbesMethods

Clariti 20/20

QDx Pathology Services, Inc.
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

Clariti Diagnostics Laboratories LLC
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
3930
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

COLARIS AP

Myriad Genetics, Inc.
United States
12
  • C Sequence analysis of the entire coding region

PREVENTEST

GeneID Lab - Advanced Molecular Diagnostics
United States
6034
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Otogenetics Hereditary Cancers

Otogenetics
United States
3639
  • E Sequence analysis of select exons

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Hereditary Colon and Endometrial Cancer-ColoNGS

GeneKor MSA
Greece
107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Familial Adenomatosis Polyposis

GeneKor MSA
Greece
52
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

APC Gene Targeted Mutation Analysis

GENETIX Centro de Investigación en Genética Humana y Reproductiva
Colombia
31
  • E Sequence analysis of select exons

myRisk Hereditary Cancer

Myriad Genetics, Inc.
United States
3246
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

APC - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

APC - MLPA

Centogene US, LLC - The Rare Disease Company
United States
51
  • D Deletion/duplication analysis

CentoColon

Centogene US, LLC - The Rare Disease Company
United States
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene US, LLC - The Rare Disease Company
United States
11468
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene US, LLC - The Rare Disease Company
United States
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene US, LLC - The Rare Disease Company
United States
218135
  • C Sequence analysis of the entire coding region

CentoColon

Centogene AG - the Rare Disease Company
Germany
6733
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer

Centogene AG - the Rare Disease Company
Germany
11468
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 187

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.